PATH (Protocol for the Assessment of the Tumor HER2 status)

PATH (Protocol for the Assessment of the Tumor HER2 status) is a guideline used by healthcare professionals to determine the presence of the HER2 protein in cancer cells, particularly in breast cancer. HER2 positive cancers can grow faster and may require specific targeted treatments. The PATH ensures that testing is done accurately and consistently across laboratories, improving diagnosis and treatment decisions for patients. By following these protocols, doctors can better tailor therapies, leading to more effective outcomes for those with HER2 positive tumors.